Marijuana and chronic obstructive lung disease: A population-based study

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 8, 2009, Pages 814-820

  Tan, Wan C ^a,b,c   Bsc, Christine Lo ^a   Jong, Aimee ^a   Xing, Li ^a   Gerald, Mark J Fitz ^b   Vollmer, William M ^c   Buist, Sonia A ^d   Sin, Don D ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; SALBUTAMOL;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; CANNABIS SMOKING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RANDOM SAMPLE; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SMOKING; SPIROMETRY; TOBACCO;

EID: 65349185089     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081040     Document Type: Article

References (22)

1. Substance Abuse and Mental Health Services Administration (SAMHSA). National Household Survey on Drug Abuse, 1998. 2nd ICPSR version. Research Triangle Park (NC): Research Triangle Institute, Inter-university Consortium for Political and Social Research; 2000.
2. World drug report 2006. New York (NY): United Nations Office on Drugs and Crime; 2006. Available: www.unodc.org/pdf/WDR-2006/wdr2006-volume1.pdf (accessed 2009 Jan. 14).
3. Adlaf EM, Begin P, Sawka E, editors. Canadian Addiction Survey (CAS): a national survey of Canadians' use of alcohol and other drugs: prevalence of use and related harms: detailed report. Ottawa (ON): Canadian Centre on Substance Abuse; 2005.
4. Moore BA, Augustson EM, Moser RP, et al. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med 2005;20:33-7.
5. Timberlake DS, Haberstick BC, Hopfer CJ, et al. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug Alcohol Depend 2007;88:272-81.
6. Faeh D, Viswanathan B, Chiolero A, et al. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health2006;6:169.
7. Sparacino CM, Hyldburg PA, Hughes TJ. Chemical and biological analysis of marijuana smoke condensate. NIDA Res Monogr1990;99:121-40.
8. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167:221-8.
9. Tashkin DP, Shapiro BJ, Lee YE, et al. Subacute effects of heavy marijuana smoking on pulmonary function in healthy men. N Engl J Med 1976;294:125-9.
10. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis1987;135:209-16.
11. Tashkin DP, Simmons MS, Sherrill DL, et al. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am J Respir Crit Care Med 1997;155:141-8.
12. Aldington S, Williams M, Nowitz M, et al. The effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62:1058-63.
13. Taylor DR, Fergusson DM, Milne BJ, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97:1055-61.
14. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-83.
15. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
16. Tan W, Sin D, Balson D, et al. The burden of obstructive lung disease (BOLD) study in Vancouver, Canada - sampling and recruitment. Can Respir J 2007; 14(Suppl A):7A-9A.
17. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management andprevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med2007;176:532-55.
18. Sherrill DL, Krzyzanowski M, Bloom JW, et al. Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population. Int J Epidemiol 1991;20:132-7.
19. National Survey on Drug Use and Health. Rockville (MD): US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies; 2004. NSDUH Series H-27, DHHS Publication no. SMA 05-4061. Available: www.oas.samhsa.gov/NSDUH.htm (accessed 2009 Jan. 15).
20. Compton WM, Grant BF, Colliver JD, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004;291:2114-21.
21. Hernandez MJ, Martinez F, Blair HT, et al. Airway response to inhaled histamine in asymptomatic long-term marijuana smokers. J Allergy Clin Immunol 1981;67: 153-5.
22. Tashkin DP, Simmons MS, Chang P, et al. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am Rev Respir Dis1993;147:97-103.